Sensei Biotherapeutics (SNSE) Competitors $11.94 +0.46 (+3.96%) As of 11:16 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SNSE vs. LTRN, FGEN, TPST, NEUP, TELO, NBRV, PDSB, LIMN, MDCX, and ZIVOShould you be buying Sensei Biotherapeutics stock or one of its competitors? The main competitors of Sensei Biotherapeutics include Lantern Pharma (LTRN), FibroGen (FGEN), Tempest Therapeutics (TPST), Neuphoria Therapeutics (NEUP), Telomir Pharmaceuticals (TELO), Nabriva Therapeutics (NBRV), PDS Biotechnology (PDSB), Liminatus Pharma (LIMN), Medicus Pharma (MDCX), and ZIVO Bioscience (ZIVO). These companies are all part of the "pharmaceutical products" industry. Sensei Biotherapeutics vs. Its Competitors Lantern Pharma FibroGen Tempest Therapeutics Neuphoria Therapeutics Telomir Pharmaceuticals Nabriva Therapeutics PDS Biotechnology Liminatus Pharma Medicus Pharma ZIVO Bioscience Sensei Biotherapeutics (NASDAQ:SNSE) and Lantern Pharma (NASDAQ:LTRN) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, media sentiment, institutional ownership and risk. Do analysts recommend SNSE or LTRN? Sensei Biotherapeutics presently has a consensus target price of $55.00, suggesting a potential upside of 360.83%. Lantern Pharma has a consensus target price of $25.00, suggesting a potential upside of 442.42%. Given Lantern Pharma's higher possible upside, analysts clearly believe Lantern Pharma is more favorable than Sensei Biotherapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sensei Biotherapeutics 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.75Lantern Pharma 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media prefer SNSE or LTRN? In the previous week, Sensei Biotherapeutics and Sensei Biotherapeutics both had 1 articles in the media. Sensei Biotherapeutics' average media sentiment score of 0.00 equaled Lantern Pharma'saverage media sentiment score. Company Overall Sentiment Sensei Biotherapeutics Neutral Lantern Pharma Neutral Which has stronger earnings and valuation, SNSE or LTRN? Lantern Pharma is trading at a lower price-to-earnings ratio than Sensei Biotherapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSensei BiotherapeuticsN/AN/A-$30.16M-$21.31-0.56Lantern PharmaN/AN/A-$20.78M-$1.78-2.59 Is SNSE or LTRN more profitable? Sensei Biotherapeutics' return on equity of -72.13% beat Lantern Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Sensei BiotherapeuticsN/A -72.13% -61.35% Lantern Pharma N/A -99.89%-81.58% Which has more volatility and risk, SNSE or LTRN? Sensei Biotherapeutics has a beta of 0.31, indicating that its stock price is 69% less volatile than the S&P 500. Comparatively, Lantern Pharma has a beta of 1.57, indicating that its stock price is 57% more volatile than the S&P 500. Do insiders & institutionals hold more shares of SNSE or LTRN? 10.5% of Sensei Biotherapeutics shares are held by institutional investors. Comparatively, 28.6% of Lantern Pharma shares are held by institutional investors. 23.2% of Sensei Biotherapeutics shares are held by company insiders. Comparatively, 8.5% of Lantern Pharma shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummarySensei Biotherapeutics beats Lantern Pharma on 7 of the 12 factors compared between the two stocks. Get Sensei Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SNSE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SNSE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNSE vs. The Competition Export to ExcelMetricSensei BiotherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$15.04M$12.30B$9.08B$10.58BDividend YieldN/A2.28%5.69%4.71%P/E Ratio-0.5621.9786.1627.45Price / SalesN/A273.38539.92202.26Price / CashN/A47.1237.9261.55Price / Book0.3910.2813.056.77Net Income-$30.16M-$52.40M$3.30B$275.88M7 Day Performance26.50%6.10%4.55%2.63%1 Month Performance44.67%15.74%9.73%9.10%1 Year Performance32.43%32.50%85.10%35.69% Sensei Biotherapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNSESensei Biotherapeutics4.1194 of 5 stars$11.94+4.0%$55.00+360.8%+22.3%$15.04MN/A-0.5640Analyst ForecastGap UpLTRNLantern Pharma2.0246 of 5 stars$4.40+7.1%$25.00+468.2%+24.4%$47.52MN/A-2.4720Analyst ForecastFGENFibroGen4.0465 of 5 stars$11.31-3.6%$43.00+280.2%+38.9%$47.44M$29.62M-29.76570News CoverageAnalyst ForecastTPSTTempest Therapeutics1.6879 of 5 stars$10.84+4.2%$30.00+176.8%-39.2%$46.18MN/A-0.7420Analyst ForecastNEUPNeuphoria Therapeutics1.8374 of 5 stars$20.00+2.8%$28.00+40.0%N/A$45.88M$15.65M0.00N/AAnalyst DowngradeTELOTelomir Pharmaceuticals2.8014 of 5 stars$1.42+1.4%$15.00+956.3%-68.3%$45.84MN/A-2.631News CoverageAnalyst ForecastGap UpHigh Trading VolumeNBRVNabriva TherapeuticsN/AN/AN/AN/A$45.46M$35.59M0.0070PDSBPDS Biotechnology1.6696 of 5 stars$0.96-5.6%$10.00+938.7%-71.9%$45.27MN/A-1.0520Analyst ForecastLIMNLiminatus PharmaN/A$1.73flatN/AN/A$45.01MN/A0.00N/AEarnings ReportAnalyst ForecastMDCXMedicus Pharma2.6529 of 5 stars$2.52-0.8%$23.50+832.5%N/A$44.90MN/A-1.88N/AAnalyst ForecastZIVOZIVO Bioscience0.1387 of 5 stars$11.75-2.3%N/A-38.5%$44.85M$15.85K-2.4110Gap Up Related Companies and Tools Related Companies LTRN Alternatives FGEN Alternatives TPST Alternatives NEUP Alternatives TELO Alternatives NBRV Alternatives PDSB Alternatives LIMN Alternatives MDCX Alternatives ZIVO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SNSE) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA Huge Shift Is Underway in AmericaWall Street legend issues chilling new warning: "I've never seen anything as dangerous as this" The man who...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sensei Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sensei Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
